Real-World, Registry to Evaluate the Effectiveness, Safety and Durability of SUPERAStent for the Treatment of De Novo or Restenotic SuperficialFemoral Artery or Complex Femoropopliteal Artery Lesions
Not Applicable
- Conditions
- Health Condition 1: I739- Peripheral vascular disease, unspecified
- Registration Number
- CTRI/2019/09/021451
- Lead Sponsor
- Dr Rajiv Parakh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either sex aged >=18 years.
2. Patients willing to sign the informed consent form (ICF) to share the data.
3. Patients with de novo or restenotic lesions in the superficial femoral artery or femoropopliteal segment treated successfully ( <30% diameter stenosis with no procedural complications) with SUPERA stent.
Exclusion Criteria
1. Patients unwilling to sign the ICF.
2. Patients with age <18 years or >90 years.
3. Patients with other comorbidities that may limit life expectancy to less than one year.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method